Abstract:BACKGROUND:This study was designed to obtain a recombinant retroviral vector containing the human hepatocellular carcinoma-related gene ANGPTL4 (angiopoietin-like 4) cDNA and to evaluate the anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.METHODS:ANGPTL4 cDNA was cloned in vitro from normal human liver cells HL-7702 by using RT-PCR, and then subcloned into the plasmid vector pMSCV and sequenced. The retroviral plasmid vectors pMSCV-ANGPTL4, pVSV, and pGAG-POL were co-transfected into the packaging cell line 293 EBNA under mediation of lipofectamine. A high-titer retrovirus was obtained as a result, and HepG2 cells were infected with this retrovirus in vitro. Flow cytometry and fluorescence microscopy were used to detect expression of green fluorescence protein (GFP). The expression of ANGPTL4 mRNA in HepG2-ANGPTL4 cells was investigated using RT-PCR. The formation of tumors in nude mice and MTT assays were used to detect the growth of HepG2-ANGPTL4 cells in vivo and in vitro, respectively.RESULTS:The cDNA sequence of the cloned ANGPTL4 gene was consistent with the recently reported sequence. Thus, the recombinant retroviral vector pMSCV-ANGPTL4 was constructed successfully. The titer of the packaged recombinant retrovirus was 1.4 x 10(6) infective viral grains/ml, and the rate of HepG2-ANGPTL4 cells expressing GFP was 68.45%, with an average intensity of fluorescence 31.67 times greater in HepG2-ANGPTL4 cells than in HepG2 cells. The expression of ANGPTL4 mRNA in HepG2-ANGPTL4 cells was higher than in HepG2-pMSCV cells (154% higher) or HepG2 cells (161% higher). The proliferation rate of HepG2-ANGPTL4 cells in vitro was obviously lower than those of HepG2-pMSCV cells and HepG2 cells (P <0.01). The mean volume and weight of tumors seeded from HepG2-ANGPTL4 cells were obviously lower than the mean volume or weight of tumors seeded from HepG2 cells and HepG2-pMSCV cells (P <0.01).CONCLUSION:A stable ANGPTL4-transfected human liver cancer cell line HepG2-ANGPTL4 has been created. The transfer of the human ANGPTL4 gene mediated by a retroviral vector is a possibly effective approach for liver cancer therapy.

Anti-Angiogenic Activity of Naked Plasmid Encoding Targeting Recombinant Platelet Factor 4

Anti-tumor Effect of Recombinant Retroviral Vector-Mediated Human ANGPTL4 Gene Transfection.

Construction of pcDNA3-Endo eukaryon expression plasmid and angiogenesis inhibition in vitro

Polycistronic Expression Of Human Platelet Factor 4 With Heparin-Neutralizing Activity In Escherichia Coli

[High Efficient Expression of Recombinant Human Platelet Factor IV in Pichia Pastoris].

Effects of transduction hPF4 gene on the angiogenesis factors gene expression in human lung cancer cells

A Convenient and Effective Approach for Gene Synthesis of Human Platelet Factor-4

Expression of Recombinant Spdgfrα-Fc in CHO and Its Anti-proliferation Analysis

Inhibition of Tumor Angiogenesis in Lung Cancer by T4 Phage Surface Displaying Mvegfr2 Vaccine

Construction and Application of an Artificial Microrna Expression Vector for Inhibiting PAR4

Inhibition of Angiogenesis by a Novel Small Peptide Consisting of the Active Fragments of Platelet Factor-4 and Vasostatin

Prokaryotic Expression of SA-hirudin-RGD Fusion Proteinand Identification of Its Anticoagulant and Anti-platelet Aggregation Function

Establishment and identification of small hairpin interfering RNA eukaryotic expression vectors of human platelet-derived growth factor A

Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy.

Expression and Purification of Functional Epitope of Pigment Epithelium-Derived Factor in E. Coli with Inhibiting Effect on Endothelial Cells

Construction of Eukaryotic Expression Plasmid of Human Platelet-Derived Growth Factor-B

[Preparation of the High-Titer Retroviral Viruses for Transducting PDGF-A Gene].

[Molecular Cloning and Expression of the Cdna Encoding Angiogenesis Inhibitor K4K5 with Pichia Pastoris].

[Construction and Expression of Soluble Vascular Endothelial Growth Factor Receptor-1 Eukaryotic Expression Vector and Its Effect on Proliferation of Vascular Endothelial Cells].

Gene Transfer of Human ANGPTL4 Mediated by Recombinant Retroviral Vector Inhibits the Growth of Liver Cancer

The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo